Kidney Fibrosis: Lock out SIRT4
Chronic kidney disease is estimated to affect over 10% of the global population (Kovesdy, 2022). Its most common feature is kidney fibrosis, which is characterized by the accumulation of extracellular matrix proteins in tissues, causing structural damage that can impair the function of the kidneys (Huang et al., 2023).
Previous work revealed that complex mechanisms and protein mediators drive kidney fibrosis, including the protein TGF-β1, which plays a vital role in promoting the expression of pro-fibrotic genes. TGF-β1 acts through a well-established signaling pathway that eventually activates a set of three transcription factors – Smad2, Smad3 and Smad4 – which collectively move from the cytoplasm to the nucleus where they promote the transcription of pro-fibrotic genes (Meng et al., 2016). The transport of molecules from the cytoplasm to the nucleus occurs continuously in cells throughout the body and must be tightly controlled to prevent aberrant traffic that can drive disease.
However, directly inhibiting TGF-β1 signaling to prevent kidney fibrosis is not an ideal therapeutic strategy due to the potential adverse effects of disrupting other biological processes involving TGF-β1. Therefore, a greater understanding of the mechanisms underlying TGF-β1-induced fibrosis is required to identify alternative approaches. Now, in eLife, Lin Kang, Zhen Liang, Shu Yang and colleagues – including Guangyan Yang, Jiaqing Xiang and Xiaoxiao Yang as joint first authors – report how unusual TGF-β1-driven translocation of the protein Sirtuin 4 into the nucleus contributes to the progression of kidney fibrosis (Yang et al., 2024).
Sirtuin 4 (also known as SIRT4 for short) is normally located in the mitochondria. However, Yang et al. (who are based at the First Affiliated Hospital of Southern University of Science and Technology and Hefei University of Technology) found increased amounts of SIRT4 in the nuclei of kidney cells from patients with chronic kidney disease. Similarly, they also discovered elevated levels of nuclear SIRT4 in the kidneys of mice that had been injured during surgery to induce kidney fibrosis experimentally.
Intriguingly, Yang et al. found that deleting the gene for SIRT4 significantly reduced the extent of kidney fibrosis in mice following an injury; this occurred either globally throughout the body or specifically in the epithelial cells lining tubules in the kidney. Consistent with this finding, overexpressing the gene in the same cells markedly enhanced the extent of kidney fibrosis. Taken together, these results suggest that abnormal nuclear accumulation of SIRT4 contributes to kidney fibrosis.
To investigate the mechanism underlying SIRT4-mediated fibrosis, Yang et al. carried out experiments in human kidney tubule epithelial cells to identify which proteins interact with SIRT4 upon TGF-β1 treatment. Interestingly, SIRT4 interacted with several proteins that localized in the nucleus, including U2AF2 (short for U2 small nuclear RNA auxiliary factor 2). This protein plays an important role in assembling the molecular machinery known as a spliceosome, which removes unnecessary parts of pre-mRNA to form the mature mRNA that is translated into a protein (Zorio and Blumenthal, 1999; Agrawal et al., 2016).
Yang et al. found that TGF-β1 treatment induced SIRT4 to remove acetyl groups from U2AF2. This allowed U2AF2 to splice the pre-mRNA of a pro-fibrotic protein called CCN2 (short for cell communication network 2), causing expression of this protein to increase. Together, these findings identify the SIRT4-U2AF2-CCN2 axis as a novel mechanism of TGF-β1-induced kidney fibrosis (Figure 1).
Yang et al. next set out to explore how SIRT4 translocates from the mitochondria to the nucleus upon TGF-β1 treatment. The experiments showed that TGF-β1-induced release of SIRT4 from mitochondria occurs through pores formed by protein polymers known as BAX and BAK, which are located in the outer membrane of mitochondria (Cosentino and García-Sáez, 2017). Screening using a variety of protein inhibitors demonstrated that in order to translocate, SIRT4 must be phosphorylated by enzymes known as ERK1 and ERK2. This modification allows SIRT4 to bind to a nuclear-transport receptor called importin α1, which moves the protein into the nucleus. Finally, Yang et al. treated mice with anti-SIRT4 antibodies that only inhibit expression of SIRT4 in the nucleus, and found this targeted disruption could sufficiently alleviate surgery-induced kidney fibrosis.
These findings open an exciting avenue for the development of a novel therapeutic strategy against kidney fibrosis: to lock the ‘bad guy’ – SIRT4 – out of the nuclei of kidney cells. It is conceivable that in the future, small molecules that hinder SIRT4 from interacting with ERK1/2 or importin α1 could be screened or synthesized to treat kidney fibrosis. However, nuclear SIRT4 may play beneficial roles in other cells and tissues (Zeng et al., 2018), thus further clinical studies are needed to evaluate the safety of such a strategy.
References
-
An extended U2AF(65)-RNA-binding domain recognizes the 3’ splice site signalNature Communications 7:10950.https://doi.org/10.1038/ncomms10950
-
Bax and Bak pores: Are we closing the circle?Trends in Cell Biology 27:266–275.https://doi.org/10.1016/j.tcb.2016.11.004
-
Kidney fibrosis: from mechanisms to therapeutic medicinesSignal Transduction and Targeted Therapy 8:129.https://doi.org/10.1038/s41392-023-01379-7
-
Epidemiology of chronic kidney disease: an update 2022Kidney International Supplements 12:7–11.https://doi.org/10.1016/j.kisu.2021.11.003
-
TGF-β: the master regulator of fibrosisNature Reviews Nephrology 12:325–338.https://doi.org/10.1038/nrneph.2016.48
Article and author information
Author details
Publication history
Copyright
© 2024, Zhao and Zhou
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 256
- views
-
- 37
- downloads
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Cell Biology
The induction of adipose thermogenesis plays a critical role in maintaining body temperature and improving metabolic homeostasis to combat obesity. β3-adrenoceptor (β3-AR) is widely recognized as a canonical β-adrenergic G-protein-coupled receptor (GPCR) that plays a crucial role in mediating adipose thermogenesis in mice. Nonetheless, the limited expression of β3-AR in human adipocytes restricts its clinical application. The objective of this study was to identify a GPCR that is highly expressed in human adipocytes and to explore its potential involvement in adipose thermogenesis. Our research findings have demonstrated that the adhesion G-protein-coupled receptor A3 (ADGRA3), an orphan GPCR, plays a significant role in adipose thermogenesis through its constitutively active effects. ADGRA3 exhibited high expression levels in human adipocytes and mouse brown fat. Furthermore, the knockdown of Adgra3 resulted in an exacerbated obese phenotype and a reduction in the expression of thermogenic markers in mice. Conversely, Adgra3 overexpression activated the adipose thermogenic program and improved metabolic homeostasis in mice without exogenous ligand. We found that ADGRA3 facilitates the biogenesis of beige human or mouse adipocytes in vitro. Moreover, hesperetin was identified as a potential agonist of ADGRA3, capable of inducing adipocyte browning and ameliorating insulin resistance in mice. In conclusion, our study demonstrated that the overexpression of constitutively active ADGRA3 or the activation of ADGRA3 by hesperetin can induce adipocyte browning by Gs-PKA-CREB axis. These findings indicate that the utilization of hesperetin and the selective overexpression of ADGRA3 in adipose tissue could serve as promising therapeutic strategies in the fight against obesity.
-
- Cell Biology
- Chromosomes and Gene Expression
During oncogene-induced senescence there are striking changes in the organisation of heterochromatin in the nucleus. This is accompanied by activation of a pro-inflammatory gene expression programme – the senescence-associated secretory phenotype (SASP) – driven by transcription factors such as NF-κB. The relationship between heterochromatin re-organisation and the SASP has been unclear. Here, we show that TPR, a protein of the nuclear pore complex basket required for heterochromatin re-organisation during senescence, is also required for the very early activation of NF-κB signalling during the stress-response phase of oncogene-induced senescence. This is prior to activation of the SASP and occurs without affecting NF-κB nuclear import. We show that TPR is required for the activation of innate immune signalling at these early stages of senescence and we link this to the formation of heterochromatin-enriched cytoplasmic chromatin fragments thought to bleb off from the nuclear periphery. We show that HMGA1 is also required for cytoplasmic chromatin fragment formation. Together these data suggest that re-organisation of heterochromatin is involved in altered structural integrity of the nuclear periphery during senescence, and that this can lead to activation of cytoplasmic nucleic acid sensing, NF-κB signalling, and activation of the SASP.